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1. Introduction
This volume appears at an especially propitious time for psychiatry, clinical 
psychology, social work, and all the systematic attempts to ameliorate the morbidity 
and the mortality that is associated with abnormal function of the mind. One can 
say with conviction that many of the assumptions held by mental health professions 
for the last half century have come to be challenged and may prove to be false. What 
do I mean by this?
1. The presumptively atheoretical DSMs, III through V, have not proved to be 
tools that facilitated scientific progress in the theoretical conceptualization 
of psychopathology [1]. Nor have they provided clinicians with the kinds of 
precise diagnostic instruments that would guide treatment. The atheoretical 
descriptive precision of the DSMs introduces the problem of comorbidity 
wherein it is rarely the case that single patient will be adequately described 
by a single diagnosis. This fact greatly compromises the precision of research 
designs and has led us into a world of polypharmacy that makes the design of 
pharmacological or psychosocial interventions not only overly complex, but 
often reduces it to an inductive process of trial and error. Drugs, that in theory 
should improve depression, sometimes turn out to be more effective with anxi-
ety. Supplementation with atypical anti-psychotics is widely practiced, though 
with limited empirical evidence.
2. The National Institute of Mental Health already has begun to move away from 
the approach of the DSMs, which is to define mental disorders based on clus-
ters of symptoms that tend to covary [2]. The approach that may substitute for 
the DSMs is the putatively more scientific RDoC, or research domain criteria. 
RDoC is an attempt to return to theory that is structured by basic psychologi-
cal dimensions: negative valence, positive valence, cognitive processes, social 
processes, and arousal/regulatory processes.
3. In the U.S. and Europe, the process for approving psychotropic drugs has 
fostered corruption and poor science. The overstated claims for the efficacy of 
psychotropic drugs has cast a pall of a field that was in the early 1990s consid-
ered on the brink of breakthrough success [3].
At this watershed moment in the mental health sciences, it is a particularly apt 
time to present an illustrious array of international experts and the scholarship 
that they bring to central and foundational issues in the field. The topics our author 
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addresses range from substance abuse to anxiety, to prenatal factors, to the patho-
genic effects of combat. These chapters are grounded in clinical observation and the 
best research practices. They represent a fascinating array of different perspective 
appropriate to the beginning of a new era in the mental health sciences.
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